Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance

Go back to Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance

Organogenesis Holding (ORGO) Reports In-Line Q4 EPS

March 1, 2023 4:37 PM EST

Organogenesis Holding (NASDAQ: ORGO) reported Q4 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $115.5 million versus the consensus estimate of $122.05 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

... More